Biodesix
BDSX22.2201.00% ( +0.220 )
Biodesix (BDSX)
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodif...
- Open
- 22.130
- High
- 23.384
- Low
- 21.780
- Prev. Close
- 22.000
- Volume
- 75.47K
- Turnover
- 1.71M
- Avg Price
- 22.633
- Bid/Ask Ratio
- --
- Amplitude
- 7.29%
- 52wk High
- 24.915
- Volume Ratio
- 1.11
- Turnover Ratio
- 1.57%
Biodesix Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$30.8338.76%
Forecast & RatingStrong buy
7analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- StockTitan · Jul 21 at 09:00 PM
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026 | BDSX Stock News
- Market Beat · Jul 19 at 05:14 AM
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Moderate Buy" by Analysts
- rttnews · Jun 29 at 03:19 AM
5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & More
- benzinga_article · Jun 15 at 08:15 AM
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- StockTitan · May 11 at 12:20 AM
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy | BDSX Stock News
- Market Beat · May 5 at 02:02 PM
Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price
